Key Record Dates
| ClinicalTrials.gov Identifier: | NCT00381550 |
|---|---|
| Brief Title: | 3-AP and Fludarabine in Treating Patients With Myeloproliferative Disorders, Chronic Myelomonocytic Leukemia, or Accelerated Phase or Blastic Phase Chronic Myelogenous Leukemia |
| First Submitted : | September 26, 2006 |
| First Submitted that Met QC Criteria : | September 26, 2006 |
| First Posted : | September 28, 2006 (Estimate) |
| Results First Submitted : | April 23, 2014 |
| Results First Submitted that Met QC Criteria : | April 23, 2014 |
| Results First Posted : | May 21, 2014 (Estimate) |
| Last Update Submitted that Met QC Criteria : | December 16, 2014 |
| Last Update Posted : | January 6, 2015 (Estimate) |